Celldex Therapeutics, Inc. Increase (Decrease) in Other Operating Assets
Celldex Therapeutics, Inc. (CLDX) reported Increase (Decrease) in Other Operating Assets of $2.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-06
- Celldex Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $0.00.
- Celldex Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $2.08M, a 213.60% increase year-over-year.
- Celldex Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $3.99M.
- Celldex Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $64.00K.
- Celldex Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2025 was $3.61M, a 62.54% decline from fiscal 2024.
- Celldex Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2024 was $9.64M, a 321233.33% increase from fiscal 2023.
- Celldex Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2023 was $3.00K.
- Celldex Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2021 was $5.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.08M 10-Q · filed 2026-08-06 | $6.07M derived: sum of 3 quarters · filed 2026-08-06 | $6.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.08M 10-Q · filed 2026-05-07 | $6.07M derived: sum of 2 quarters · filed 2026-05-07 | $6.13M derived: sum of 3 quarters · filed 2026-05-07 | $5.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.06M derived: sum of 2 quarters · filed 2026-02-25 | $2.95M derived: sum of 3 quarters · filed 2026-08-06 | $3.61M 10-K · filed 2026-02-25 |
| 2025-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.04M derived: sum of 2 quarters · filed 2026-08-06 | -$383.00K 10-Q · filed 2025-11-10 | -$383.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$447.00K 10-Q · filed 2026-08-06 | -$447.00K derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-03-31 | $662.00K 10-Q · filed 2026-05-07 | $662.00K derived: sum of 2 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $9.64M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $9.64M 10-Q · filed 2025-11-10 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $3.00K 10-K · filed 2026-02-25 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.00K 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-08 | |||
| 2021-12-31 | $5.00K 10-K · filed 2024-02-26 | |||
| 2019-12-31 | $39.00K 10-K · filed 2022-02-28 | |||
| 2017-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$6.00K derived: sum of 2 quarters · filed 2020-03-26 | -$6.00K derived: sum of 3 quarters · filed 2020-03-26 | -$205.00K 10-K · filed 2020-03-26 |
| 2017-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $67.00K derived: sum of 2 quarters · filed 2018-11-07 | -$132.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$199.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | -$199.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $89.00K 10-K · filed 2019-03-07 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$104.00K derived: sum of 2 quarters · filed 2018-03-07 | -$172.00K derived: sum of 3 quarters · filed 2018-03-07 | -$6.00K 10-K · filed 2018-03-07 |
| 2015-09-30 | -$104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$172.00K derived: sum of 2 quarters · filed 2016-11-07 | -$6.00K 10-Q · filed 2016-11-07 | -$22.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $98.00K 10-Q · filed 2016-08-08 | $82.00K derived: sum of 3 quarters · filed 2017-03-14 | $65.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $166.00K 10-Q · filed 2016-05-05 | $150.00K derived: sum of 2 quarters · filed 2017-03-14 | $133.00K derived: sum of 3 quarters · filed 2017-03-14 | $117.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$33.00K derived: sum of 2 quarters · filed 2017-03-14 | -$49.00K derived: sum of 3 quarters · filed 2017-03-14 | -$65.00K 10-K · filed 2017-03-14 |
| 2014-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$33.00K derived: sum of 2 quarters · filed 2015-11-05 | -$49.00K 10-Q · filed 2015-11-05 | -$58.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$32.00K 10-Q · filed 2015-08-10 | -$41.00K derived: sum of 3 quarters · filed 2016-02-25 | -$58.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$16.00K 10-Q · filed 2015-04-29 | -$25.00K derived: sum of 2 quarters · filed 2016-02-25 | -$42.00K derived: sum of 3 quarters · filed 2016-02-25 | -$104.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$9.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | -$26.00K derived: sum of 2 quarters · filed 2016-02-25 | -$88.00K derived: sum of 3 quarters · filed 2016-02-25 | -$276.00K 10-K/A · filed 2016-02-25 |
| 2013-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$79.00K derived: sum of 2 quarters · filed 2014-11-05 | -$267.00K 10-Q · filed 2014-11-05 | -$252.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | -$62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$250.00K 10-Q · filed 2014-08-07 | -$235.00K derived: sum of 3 quarters · filed 2015-02-24 | -$254.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | -$188.00K 10-Q · filed 2014-05-01 | -$173.00K derived: sum of 2 quarters · filed 2015-02-24 | -$192.00K derived: sum of 3 quarters · filed 2015-02-24 | -$224.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$4.00K derived: sum of 2 quarters · filed 2015-02-24 | -$36.00K derived: sum of 3 quarters · filed 2015-02-24 | $95.00K 10-K · filed 2015-02-24 |
| 2012-09-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$51.00K derived: sum of 2 quarters · filed 2013-11-08 | $80.00K 10-Q · filed 2013-11-08 | $61.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $99.00K 10-Q · filed 2013-08-06 | $80.00K derived: sum of 3 quarters · filed 2014-03-03 | $61.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $131.00K 10-Q · filed 2013-05-03 | $112.00K derived: sum of 2 quarters · filed 2014-03-03 | $93.00K derived: sum of 3 quarters · filed 2014-03-03 | $60.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$38.00K derived: sum of 2 quarters · filed 2014-03-03 | -$71.00K derived: sum of 3 quarters · filed 2014-03-03 | -$34.00K 10-K · filed 2014-03-03 |
| 2011-09-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$52.00K derived: sum of 2 quarters · filed 2012-11-02 | -$15.00K 10-Q · filed 2012-11-02 | -$5.05M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $4.00K 10-Q · filed 2012-08-09 | -$5.03M derived: sum of 3 quarters · filed 2013-03-08 | -$5.21M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | $37.00K 10-Q · filed 2012-05-04 | -$5.00M derived: sum of 2 quarters · filed 2013-03-08 | -$5.18M derived: sum of 3 quarters · filed 2013-03-08 | |
| 2010-12-31 | -$5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | -$5.22M derived: sum of 2 quarters · filed 2013-03-08 | -$5.59M 10-K · filed 2013-03-08 | |
| 2010-09-30 | -$181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$554.00K 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$373.00K 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$722.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |